#59: NewsBot: Oscient Pharmaceuticals to Participate in the Roth Capital Partners 20th Annual OC Growth Conference
Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in
the... |
April 7, 2008
09:43:18 PM |
#58: FastFun: Post Conference and Q3 Focus on CytRx Corporation, Oscient Pharmaceuticals Corporation, and Santarus, Inc.
Awareness Brings Added ValueComments made in this release are those of... |
October 20, 2007
10:32:20 PM |
#57: FastFun: Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Third Quarter Financial Results
Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial... |
October 20, 2007
10:31:43 PM |
#56: FastFun: Oscient Pharmaceuticals Provides Preliminary Revenue Results for the Third Quarter of 2007
Revenues increase approximately 25 percent from third quarter of 2006;... |
October 20, 2007
10:30:37 PM |
#55: FastFun: Oscient Pharmaceuticals to Participate in the Natixis Bleichroeder Hidden Gems Conference
Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in... |
October 20, 2007
10:29:40 PM |
#54: NewsBot: OSCI News Oscient Pharmaceuticals Commences Exchange Offers
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
March 29, 2007
04:33:00 AM |
#53: NewsBot: OSCI News Oscient Pharmaceuticals Files Registration Statements for Proposed Exchange Offers with Holders of its Convertible Notes and an Offering of up to $30,000,000 Principal Amount of New 3.50% Convertible Senior Notes due 2011
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
March 15, 2007
04:17:00 AM |
#52: NewsBot: OSCI News CORRECTED: Webcast Alert: Oscient Pharmaceuticals to Present at Cowen & Company 27th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
March 8, 2007
10:57:00 AM |
#51: NewsBot: OSCI News Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
MONTREAL and WALTHAM, Mass.--(BUSINESS WIRE)--Abbott Canada, the Canadian... |
March 2, 2007
05:30:00 AM |
#50: NewsBot: OSCI News Oscient Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2006
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
February 27, 2007
04:30:00 AM |
#49: NewsBot: OSCI News New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation’s... |
February 22, 2007
05:30:00 AM |
#48: NewsBot: OSCI News Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:OSCI)... |
February 15, 2007
08:38:00 AM |
#47: NewsBot: OSCI News Oscient Pharmaceuticals Provides Preliminary Revenue Results for Fourth Quarter and Fiscal Year 2006
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
January 8, 2007
06:24:00 AM |
#46: NewsBot: OSCI News Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
January 4, 2007
05:30:00 AM |
#45: NewsBot: OSCI News Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences
WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:... |
December 29, 2006
06:00:00 AM |
| 
| 
| 
| 
| 
| 
